Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “TREAT”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 325 records · Page 18

TREAT HODOSCOPE – A Predictive Simulation Model

The Transient Reactor Test Facility (TREAT) reactor is being restarted after over two decades of standby operation. TREAT is designed to test the time-dependent behavior of nuclear fuel during simulated reactor accidents. One of the principle data collection systems of TREAT is the fast neutron hodoscope which is used to observe the motion of the fuel test specimen as it is being damaged, deformed, or melted over the course of the power transient. The hodoscope is a grid of ex-core collimator channels paired with a bank of fast neutron sensitive radiation detectors. These detectors have historically been calibrated using empirical methods utilizing measurement data from smaller power pulses. Given modern computational capabilities this work sets out to establish a predictive computational capability of the fast neutron flux field exiting the hodoscope to support these calibrations.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗

Biological System Characterization to Address Biofouling of the 200 West Pump-and-Treat Injection Wells

Contaminated groundwater in the 200W Area of the Hanford Site is being treated ex situ by the 200W Pump-and-Treat (P&T) Facility and the subsurface plume is under hydraulic containment. The 200W P&T Facility removes several contaminants of concern from groundwater, as well as nitrate. Facility capacity is constrained by biofouling of injection wells, which limits the ability to efficiently inject treated effluent water in to the subsurface. In a previous report, Thomle et al. provided a comprehensive engineering assessment of biofouling at the 200W P&T Facility. In that report, both operational changes and facility modifications were recommended to help mitigate the symptoms and consequences of biofouling by expanding treatment processes in the plant. The 200W P&T Facility’s fluidized bed reactor (FBR) is a biological treatment system that has been identified as a principal source of biofouling. Carbon and nutrient inputs to the FBR are needed to sustain high rates of activity, but can also be responsible for microbial proliferation in the effluent water distribution pipeline, and loss injection well capacity. The primary objective of this work was to fill critical knowledge gaps associated with the FBR that can be used to optimize the biological system for continuous operation and sustained performance.

54 ENVIRONMENTAL SCIENCES↗

Transient Testing of Nuclear Fuels Performed in the Original Operation of TREAT, Third Edition

TREAT core was upgraded at the end of the 1980s. The tests performed since about 1970 are summarized in considerable detail. Earlier tests are noted by their designated series and by some parameters that help to identify and distinguish each series from the others. The detailed summary descriptions are intended to help inform future researchers regarding the large, historical, empirical data base generated from that 35-year span during which hundreds of TREAT experiments were performed to investigate and demonstrate the transient behavior of a wide variety of nuclear fuels during severe off-normal and accident conditions -- using direct nuclear heating of the test samples. That empirical basis is foundational and valuable for guiding future qualification and safety evaluation of improved fuel designs and for future transient test planning and performance in TREAT. The second edition of this report added descriptions of the following test series: D, E, EOS, F, H, J, R, RX, and S. This third edition includes descriptions of an additional four test series: the HUT, HOP (& HUC), ORNL-TR, and PNL.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗

Integrated Electrocoagulation, Ultrafiltration, Membrane Distillation, and Crystallization for Treating Produced Water

Produced water (PW) generated from hydraulic fracturing operations was treated using an integrated electrocoagulation, ultrafiltration, membrane distillation, and crystallization process (EC UF MDC). The aim was to determine the viability of this integrated process for maximizing water recovery. The results obtained here indicate that optimizing the various unit operations could lead to increased recovery of PW. Membrane fouling limits all membrane separation processes. A pretreatment step to suppress fouling is essential. Here, removal of total suspended solids (TSS) and total organic carbon (TOC) was achieved by electrocoagulation (EC) followed by ultrafiltration (UF). The hydrophobic membrane used in membrane distillation may be fouled by dissolved organic compounds. Reducing membrane fouling is essential to increase the long-term durability of the membrane distillation (MD) system. In addition, combining membrane distillation with crystallization (MDC) can help reduce scale formation. By inducing crystallization in the feed tank, scale formation on the MD membrane was suppressed. The integrated EC UF MDC process can impact Water Resources/Oil & Gas Companies. Conservation of surface and groundwater is possible by treating and reusing PW. Additionally, treating PW reduces the amount of PW disposed in Class II disposal wells and promotes more environmentally sustainable operations.

42 ENGINEERING↗

High tip speed fan inlet noise reduction using treated inlet splitters and accelerating inlets (quiet engine program fan C scale model)

A series of inlet suppression tests were run on a supersonic tip speed fan which employed an acoustically treated cowl wall, treated splitters and elevated average throat Mach numbers in various combinations. Results show appreciable fan noise reductions at high fan speeds; 15-18 PNdB. On the basis of inlet total pressure recovery loss per PNdb of noise reduction, an inlet with no splitters produced the most efficient design. However, greater reduction in noise was achieved with one splitter in the inlet. It was also noted that moderate increases in inlet Mach number increased noise in the acoustically treated inlets and that Mach numbers in excess of 0.65 were required before net noise reduction was realized.

Kazin, S. B.↗

Method of heat treating a formed powder product material

Heat treating a product material of prealloyed powders after shaping by superplastic deformation restores the ability of the material to resist deformation at high temperatures. Heat treating is accomplished by heating to a temperature between the solidus and liquidus with the application of isostatic pressure to close any voids. This pressure may be simultaneously applied while the material is at the heat treating temperature. The pressure may also be applied when the material cools to a temperature between that at which it is shaped and the solidus.

Freche, J. C.↗

Effect of Serum from Chickens Treated with Clenbuterol on Myosin Accumulation, Beta-Adrenergic Receptor Population, and Cyclic AM Synthesis in Embryonic Chicken Skeletal Muscle Cell Cultures

Broiler chickens at 35 days of age were fed 1 ppm clenbuterol for 14 days. This level of dietary clenbuterol led to 5-7% increases in weights of leg and breast muscle tissue. At the end of the 14-day period, serum was prepared from both control and clenbuterol-treated chickens and was then employed as a component of cell culture media at a final concentration of 20% (v/v). Muscle cell cultures were prepared from both the leg and breast muscle groups of twelve-day chick embryos. Treatment groups included control chicken serum to which 10 nM, 50 nM, and 1 micron clenbuterol had been added, as well as cells grown in media containing 10% horse serum. Cultures were subjected to each treatment for 3 days beginning on the seventh day in culture. Neither the percent fusion nor the number of nuclei in myotubes were significantly affected by any of the treatments. The quantity of MHC was not increased by serum from clenbuterol-treated chickens in either breast and leg muscle cultures; however, MHC quantity was 50- 100% higher in cultures grown in control chicken serum to which 10 nM and 50 nM clenbuterol had also been added. The Beta-AR population was 4,000-7,000 Beta-AR per cell in cultures grown in chicken serum, with leg muscle cultures having approximately 25-30% more receptors than breast muscle cultures. Receptor population was not significantly affected by the presence of clenbuterol or by the presence of serum from clenbuterol-treated chickens. In contrast, the Beta-AR population in leg and breast muscle cultures grown in the presence of 10% horse serum was 18,000-20,000 Beta-AR per cell. Basal concentration of cAMP was not significantly affected by any of the treatments. When cultures grown in chicken serum were stimulated for 10 min with 1 micron isoproterenol, limited increases of 12-20% in cAMP concentration above basal levels were observed. However, when cultures grown in the presence of horse serum were stimulated with 1 micron isoproterenol, increases of 600-800 % in cAMP concentration above basal levels were observed. Thus, not only did cells grown in horse serum have a higher Beta-AR population, each receptor had a higher capacity for cAMP synthesis following isoproterenol stimulation. Finally, the hypothesis was tested that clenbuterol exerts its action on muscle protein content by changes in cAMP concentration. No correlation was apparent between basal cAMP concentration and MHC content.

Young, R. B.↗

Effect of Serum from Chickens Treated with Clenbuterol on Myosin Accumulation, Beta-Adrenergic Receptor Population, and Cyclic AMP Synthesis in Embryonic Chicken Skeletal Muscle Cell Cultures

Broiler chickens at 35 d of age were fed 1 ppm clenbuterol for 14 d. This level of dietary clenbuterol led to 5-7% increases in the weights of leg and breast muscle tissue. At the end of the 14-d period, serum was prepared from both control and clenbuterol-treated chickens, and was then employed as a component of cell culture media at a final concentration of 20% (v/v). Muscle cell cultures were prepared from both the leg and the breast muscle groups of 12-d chick embryos. Treatment groups included control chicken serum to which 10 nM, 50 nM, and 1 uM clenbuterol had been added, as well as cells grown in media containing 10% horse serum. Cultures were subjected to each treatment for 3 d, beginning on the seventh d in culture. Neither the percent fusion nor the number of nuclei in myotubes was significantly affected by any of the treatments. The quantity of myosin heavy chains (MHCs) was not increased by serum from clenbuterol-treated chickens in either breast or leg muscle cultures; however, the MHC quantity was 50-150% higher in cultures grown in control chicken serum to which 10 and 50 nM clenbuterol had also been added. The B-adrenergic receptor (betaAR) population was 4000-7000 betaARs per cell in cultures grown in chicken serum with leg muscle cultures having approximately 25-30% more receptors than breast muscle Culture. Receptor population was not significantly affected by the presence of clenbuterol or by the presence of serum from clenbuterol-treated chickens. In contrast, the betaAR Population in leg and breast muscle cultures grown in the presence of 10% horse serum was 16,000-18,000 betaARs per cell. Basal concentration of cyclic adenosine 3':5'monophosphate (cAMP) was not significantly affected by the treatments. When cultures grown in chicken serum were stimulated for 10 min with 1 uM isoproterenol, limited increases of 12-20% in cAMP Concentration above the. basal levels were observed. However, when cultures grown in the presence of horse serum were stimulated with 1 uM isoproterenol, cAMP concentration was stimulated 5- to 9-fold above the basal levels. Thus, not only did cells, grown in horse serum have a higher PAR population, but also each receptor had a higher capacity for cAMP synthesis following isoproterenol stimulation. Finally, the hypothesis that clenbuterol exerts its action on muscle protein content by changes in cAMP concentration was tested. No correlation was apparent between basal cAMP concentration and MHC content.

Young, Ronald B.↗

Mechanical Properties of Heat-treated Carbon Fibers

Carbon fibers are selected for ceramic matrix composites (CMC) are based on their as-fabricated properties or on "that is what we have always done" technical culture while citing cost and availability when there are others with similar cost and availability. However, the information is not available for proper selection of carbon fibers since heat-treated properties are not known for the fibers on the market currently. Heat-treating changes the fiber's properties. Therefore, an effort was undertaken to establish fiber properties on 19 different types of fibers from six different manufactures for both PAN and pitch fibers. Heat-treating has been done at three different temperatures.

Effinger, Michael R.↗

Study of Low Temperature Baking Effect on Field Emission on Nb Samples Treated by BEP, EP, and BCP

Field emission is still one of the major obstacles facing Nb superconducting radio frequency (SRF) community for allowing Nb SRF cavities to reach routinely accelerating gradient of 35 MV/m that is required for the international linear collider. Nowadays, the well know low temperature backing at 120 oC for 48 hours is a common procedure used in the SRF community to improve the high field Q slope. However, some cavity production data have showed that the low temperature baking may induce field emission for cavities treated by EP. On the other hand, an earlier study of field emission on Nb flat samples treated by BCP showed an opposite conclusion. In this presentation, the preliminary measurements of Nb flat samples treated by BEP, EP, and BCP via our unique home-made scanning field emission microscope before and after the low temperature baking are reported. Some correlations between surface smoothness and the number of the observed field emitters were found. The observed experimental results can be understood, at least partially, by a simple model that involves the change of the thickness of the pent-oxide layer on Nb surfaces.

43 PARTICLE ACCELERATORS↗

First-Principles Calculations, Electrochemical and X-ray Absorption Studies of Li-Ni-PO4 Surface-Treated xLi2MnO3 (1 x)LiMO2 (M = Mn, Ni, Co) Electrodes for Li-Ion Batteries

It has been previously hypothesized that the enhanced rate capability of Li-Ni-PO{sub 4}-treated xLi{sub 2}MnO{sub 3} {center_dot} (1-x)LiMO{sub 2} positive electrodes (M = Mn, Ni, Co) in Li-ion batteries might be associated with a defect Ni-doped Li{sub 3}PO{sub 4} surface structure [i.e., Li{sub 3-2y}Ni{sub y}PO{sub 4} (0 < y < 1)], thereby promoting fast Li{sup +}-ion conduction at the xLi{sub 2}MnO{sub 3} {center_dot} (1-x)LiMO{sub 2} particle surface. In this paper, the solubility of divalent metals (Fe, Mn, Ni, Mg) in {gamma}-Li{sub 3}PO{sub 4} is predicted with the first-principles GGA+U method in an effort to understand the enhanced rate capability. The predicted solubility (x) is extremely small; this finding is consistent with experimental evidence: 1) X-ray diffraction data obtained from Li-Ni-PO{sub 4}-treated xLi{sub 2}MnO{sub 3} {center_dot} (1-x)LiMO{sub 2} electrodes that show that, after annealing at 550 C, a Li{sub 3}PO{sub 4}-like structure forms as a second phase at the electrode particle surface, and 2) X-ray absorption spectroscopy, which indicate that the nickel ions are accommodated in the transition metal layers of the Li{sub 2}MnO{sub 3} component during the annealing process. However, electrochemical studies of Li{sub 3-2y}Ni{sub y}PO{sub 4}-treated xLi{sub 2}MnO{sub 3} {center_dot} (1-x)LiMO{sub 2} electrodes indicate that their rate capability increases as a function of y over the range y = 0 (Li{sub 3}PO{sub 4}) to y = 1 (LiNiPO{sub 4}), strongly suggesting that, at some level, the nickel ions play a role in reducing electrochemical impedance and increasing electrode stability at the electrode particle surface.

25 ENERGY STORAGE↗

Method and apparatus for treating a cellulosic feedstock

Methods and apparatus for treating, pre-treating, preparing and conveying a cellulosic feedstock, such as for ethanol production, are disclosed. More specifically, the invention relates to methods and apparatus for treating a cellulosic feedstock by mixing and heating the cellulosic feedstock and/or by moistening and heating the cellulosic feedstock. The invention also relates to a holding tank, and a method of utilizing the holding tank whereby bridging may be reduced or eliminated and may result in a product stream from autohydrolysis or hydrolysis having an improved yield. The invention further relates to methods and apparatus for obtaining and conveying a cellulosic feedstock, which may be used for the subsequent production of a fermentable sugar stream from the cellulose and hemicellulose in the cellulosic feedstock wherein the fermentable sugar stream may be used for subsequent ethanol production. The invention also relates to a method and apparatus for withdrawing one or more feedstock stream from a holding tank.

09 BIOMASS FUELS↗

Sequential Pattern Mining of Electronic Healthcare Reimbursement Claims: Experiences and Challenges in Uncovering How Patients are Treated by Physicians

We examine the use of electronic healthcare reimbursement claims (EHRC) for analyzing healthcare delivery and practice patterns across the United States (US). We show that EHRCs are correlated with disease incidence estimates published by the Centers for Disease Control. Further, by analyzing over 1 billion EHRCs, we track patterns of clinical procedures administered to patients with autism spectrum disorder (ASD), heart disease (HD) and breast cancer (BC) using sequential pattern mining algorithms. Our analyses reveal that in contrast to treating HD and BC, clinical procedures for ASD diagnoses are highly varied leading up to and after the ASD diagnoses. The discovered clinical procedure sequences also reveal significant differences in the overall costs incurred across different parts of the US, indicating a lack of consensus amongst practitioners in treating ASD patients. We show that a data-driven approach to understand clinical trajectories using EHRC can provide quantitative insights into how to better manage and treat patients. Based on our experience, we also discuss emerging challenges in using EHRC datasets for gaining insights into the state of contemporary healthcare delivery and practice in the US.

Pullum, Laura L↗

Pre-treating water with non-thermal plasma

The present invention consists of a method of pre-treatment of adulterated water for distillation, including adulterated water produced during hydraulic fracturing ("fracking") of shale rock during natural gas drilling. In particular, the invention is directed to a method of treating adulterated water, said adulterated water having an initial level of bicarbonate ion in a range of about 250 ppm to about 5000 ppm and an initial level of calcium ion in a range of about 500 ppm to about 50,000 ppm, said method comprising contacting the adulterated water with a non-thermal arc discharge plasma to produce plasma treated water having a level of bicarbonate ion of less than about 100 ppm. Optionally, the plasma treated water may be further distilled.

03 NATURAL GAS↗

Methods for treating a metathesis feedstock with metal alkoxides

Various methods are provided for treating and reacting a metathesis feedstock. In one embodiment, the method includes providing a feedstock comprising a natural oil, chemically treating the feedstock with a metal alkoxide under conditions sufficient to diminish catalyst poisons in the feedstock, and, following the treating, combining a metathesis catalyst with the feedstock under conditions sufficient to metathesize the feedstock.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Developing the test conditions for the first fueled transients in the TREAT reactor

The restart of the Transient Reactor Test (TREAT) facility at Idaho National Laboratory, re-establishes a national in-pile testing capability for nuclear fuels in accident scenarios. The purpose of the first tests in TREAT are to study the response of nuclear fuel durring a reactivity initiated accident (RIA). The initial objective is to demonstrate the ability to create a desired enthalpy increase in a representative fuel test specimen over a desired time step and to better understand the uncertainty. The five test rods initially available for these irradiations are UO2-Zircaloy with standard Pressurized Water Reactor (PWR) geometry. The rods are 15 cm long with 9 cm of active fuel. The initial testing environment is dry helium. BISON fuel performance calculations were run to model the heat transfer during postulated transients. Based on those results energy deposition targets were selected around the range of observable phenomena in the testing environment. Reactor / experiment power coupling factors, step insertion size and transient clipping response times were then calculated using results from a RELAP point kinetics model. Calculated energy deposition targets are 150, 350, 650, 960, and 1300 J/gUO2. The energy coupling factor for the experiments was calculated to be ~1.5 J/gUO2-MJ. Two step insertion sizes were selected: a 0.6% ?k/k step for the 150 J/g transient and a 1.8% ?k/k step for the other transients. Clipping response times ranged from 1.3 seconds to unclipped transients. The experiments will be irradiated in the TREAT facility in the fall of 2018. The first transient will be the 150 J/g pulse with a 0.6% ?k/k step that is unclipped. Follow on tests may modify the reactor operating parameters based on results from previous transients. Any preliminary data available on the results of the transients at the time of the NUMAT Conference will be presented.

11 NUCLEAR FUEL CYCLE AND FUEL MATERIALS↗